Series B Press Release
General Catalyst leads funding round joined by .406 Ventures, Valtruis, Mass General Brigham Ventures, and Hopelab Foundation to bolster insurance-based mental health program availability in new markets.
InStride Health is excited to announce that starting in May, they will be in-network with Blue Cross Blue Shield of Rhode Island.
Anthem Blue Cross and Blue Shield Expands Access to Specialty Mental Healthcare Treatment with Addition of InStride Health to Network
Pediatric mental health startup InStride Health picks up $30M to accelerate growth into new markets
Wellpoint has teamed up with InStride Health, a pediatric anxiety and obsessive-compulsive disorder (OCD) treatment provider, to its expansive provider network.
Wellpoint Increases Access to Mental Healthcare for Children and Young Adults with Addition of InStride Health to Network
Anthem recently welcomed InStride Health, a pediatric anxiety and obsessive-compulsive disorder (OCD) treatment provider, to its extensive provider network.
Mona Potter, MD and Kathryn Boger, PhD, ABPP recently partnered with ADAA to host a Q&A Supporting Your Child with Anxiety and/or OCD webinar.
Once seen as an unpleasant feature of childhood – “they’re just being kids” – bullying is now recognized as a serious problem that can have devastating consequences.
“Shaking or trembling of the hands or other parts of the body are common physical symptoms associated with social anxiety disorder (SAD) and other anxiety conditions.”
“John Voith is the CEO of InStride Health, a technology-enhanced mental health treatment for children and adolescents struggling with moderate to severe anxiety and OCD, co-founded by the clinicians who co-developed the McLean Anxiety Mastery Program at McLean Hospital. “
“Our children are facing challenges that didn’t exist just a short while ago. They are growing up with social media, constantly being connected, and the hurried pace of life today, as well as the pandemic, and the often frightening news.”
“InStride’s strategic collaboration with McLean, distinguished by their excellence in clinical care, cutting-edge research, and clinical training, positions us to respond to an urgent need to provide effective and accessible care for children and adolescents with moderate to severe anxiety and OCD.”
“There’s a shortage of providers who provide evidence-based care, take insurance and have the expertise to see kids with moderate to severe anxiety and OCD, there’s long wait lists, and when providers do become available, they’re usually self-pay oriented. That’s very expensive for families. ”
“I also have seen how life-changing the right treatment can be. It has been heartbreaking to see how hard it is for families to get help, with too many kids unnecessarily ending up in emergency rooms or inpatient units, this is why it was essential for us to build InStride and become a bigger part of the solution.”
“The right treatment provides struggling youth with “a powerful way to start to understand the world and to face new and hard challenges. And they will take the skills they learn with them for the rest of their lives.”
“There’s an anxiety epidemic, and increasing numbers of kids are struggling to learn, connect, and thrive. We need to think outside the box about how to tackle this problem.”
“When faced with anxiety, your knee-jerk reaction might be to talk yourself out of it, but this isn’t always helpful. Our body is in such high-alert…mode that talking ourselves down is not going to be powerful enough,”
General Catalyst leads funding round joined by .406 Ventures, Valtruis, Mass General Brigham Ventures, and Hopelab Foundation to bolster insurance-based mental health program availability in new markets.
InStride Health, a specialty pediatric anxiety and OCD treatment provider, released its first annual outcomes report. Based on treatment of over 350 patients, InStride Health demonstrated clinically meaningful results of its coordinated care model.
General Catalyst leads funding round joined by .406 Ventures, Valtruis, Mass General Brigham Ventures, and Hopelab Foundation to bolster insurance-based mental health program availability in new markets.
InStride Health, a specialty pediatric anxiety and OCD treatment provider, released its first annual outcomes report. Based on treatment of over 350 patients, InStride Health demonstrated clinically meaningful results of its coordinated care model.
If you are a member of the press and would like to feature InStride Health, speak to an InStride Health representative or need high-resolution photos, please contact:
Alexis Ducharme
855.438.8331 ext: 751
Privacy Policy | Children & Privacy Policy | HIPAA | Terms of Service
The clinical services offered through this website are provided by InStride Health MA, P.C., doing business in New York as “In Stride Medical,” and InStride Health NJ, P.C., each an independent, physician-owned medical group. For more information about the relationship between InStride Health, Inc., InStride Health MA, P.C., and InStride Health NJ, P.C., click here.
© InStride Health. All rights reserved.
Contact us if you have a question.
Start the application process here.